LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "systemic adverse" as a keyword



Overview of Systematic Reviews and Meta-analyses on Systemic Adverse Events Associated With Intravitreal Anti–Vascular Endothelial Growth Factor Medication Use

Sign Up to like & get
recommendations! Published in 2018 at "JAMA Ophthalmology"

DOI: 10.1001/jamaophthalmol.2018.0002

Abstract: Importance The systemic safety of intravitreal anti–vascular endothelial growth factor (anti-VEGF) medications is still a matter of debate. Objective This overview of systematic reviews evaluates systemic adverse events associated with intravitreal anti-VEGF treatments in patients… read more here.

Keywords: meta analyses; systemic adverse; risk; intravitreal anti ... See more keywords

Targeting Bortezomib to Bone Increases Its Bone Anabolic Activity and Reduces Systemic Adverse Effects in Mice

Sign Up to like & get
recommendations! Published in 2019 at "Journal of Bone and Mineral Research"

DOI: 10.1002/jbmr.3889

Abstract: Bortezomib (Btz) is a proteasome inhibitor approved by the FDA to treat multiple myeloma. It also increases bone volume by promoting osteoblast differentiation and inhibiting osteoclastogenesis in mice. However, Btz has severe systemic adverse effects,… read more here.

Keywords: systemic adverse; bone anabolic; bone; mice ... See more keywords

Systemic adverse drug events to topical prostaglandin analogs for treating glaucoma: a retrospective focused pharmacovigilance study

Sign Up to like & get
recommendations! Published in 2024 at "BMC Ophthalmology"

DOI: 10.1186/s12886-024-03823-w

Abstract: Prostaglandin analogs are first-line treatments for open-angle glaucoma due to their proven efficacy in reducing intraocular pressure. Despite their topical administration, systemic adverse drug Events (ADEs) have been reported. This study investigates the systemic ADEs… read more here.

Keywords: adverse drug; prostaglandin analogs; systemic adverse; topical prostaglandin ... See more keywords

Safety of House Dust Mite Subcutaneous Immunotherapy with a rush and cluster combination protocol in the build-up phase.

Sign Up to like & get
recommendations! Published in 2023 at "Asian Pacific journal of allergy and immunology"

DOI: 10.12932/ap-260922-1465

Abstract: BACKGROUND Conventional and cluster subcutaneous immunotherapy (SCIT) are effective but may be time-consuming. Rush SCIT may offer a more convenient treatment option to patients and be of shorter duration; however, it is also associated with… read more here.

Keywords: adverse reactions; combination; rush cluster; systemic adverse ... See more keywords